trending Market Intelligence /marketintelligence/en/news-insights/trending/5_LZodu_bKO2PCe_41tK7g2 content esgSubNav
In This List

Athyrium, Neuberger Berman close healthcare fund at $2.03B

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Athyrium, Neuberger Berman close healthcare fund at $2.03B

Athyrium Capital Management LP and Neuberger Berman Group LLC have closed Athyrium Opportunities Fund III at approximately $2.03 billion.

The fund will be used to make investments of $20 million to $300 million in commercial-stage healthcare companies in North America, Europe, Asia and Australia. The fund invests across the healthcare sector, including pharmaceuticals, medical products, diagnostics, healthcare services and healthcare information technology.

NB Alternatives Advisers LLC acts as a sub-adviser to the fund.